首页
产品
黄页
商标
征信
会员服务
注册
登录
全部
|
企业名
|
法人/股东/高管
|
品牌/产品
|
地址
|
经营范围
发明名称
Anordning ved en apparatboks og/eller et ledningsrör for elektriske installasjoner
摘要
申请公布号
NO940477(A)
申请公布日期
1994.08.15
申请号
NO19940000477
申请日期
1994.02.11
申请人
IDEALPLAST AB
发明人
HAGBERG, ROLAND
分类号
H02G;H02G3/02;H02G3/06;H02G3/18;(IPC1-7):H02G3/18
主分类号
H02G
代理机构
代理人
主权项
地址
您可能感兴趣的专利
Helmet mounted display system adjustable for bright ambient light conditions
Site-specific serine recombinases and methods of their use
SYSTEM FOR USING HIGH ROTARY SPEED FOR MINIMIZING THE LOAD DURING FRICTION STIR WELDING
SESSION ESTABLISHMENT METHOD, SERVER, DEVICE, SYSTEM AND APPARATUS
Desk Lamp
APPRATUS FOR SENSING ENVIRONMENT INFORMATIONS IN GREENHOUSE
Methods for increasing and mobilizing hematopoietic stem cells
2-(5-(4-cyanonaphthalen-1-yl) pyridine-4-ylthio)-2-methylpropanoic acid, pharmaceutical composition comprising it and its use in the manufacture of a medicament
Pyrazolo piperidine derivatives, compositions comprising the same and uses thereof
Polyhalite imi process of commercial quality potassium nitrate from polyhalite
Visible light absorbers for ophthalmic lens materials
High frequency automatic link establishment communication system with wideband probe and related method
Aqueous concentrate formulations containing saflufenacil and glyphosate
Method of producing differentiated human cells from human embryonic stem cells
Method for separating and purifying alpha-unsaturated amine compound
Semi automatic pistol slide pull
Compositions and kits comprising 4-phenyl-2-propionamidotetralin (4-p-pdot) and uses of 4-p-pdot in the manufacture of medicaments for the correction of an imbalance between bone resorption and bone formation
Ctla4 molecule for use in preventing the development of rheumatoid arthritis in subjects with early onset undifferentiated arthritis
Formulation suitable for subcutaneous administration comprising ctla4ig molecules, sugar and a pharmaceutically acceptable aqueous carrier and use thereof for preparation of a medicament
Composition comprising dendritic cells partially matured in vitro
